Articles

Serena Williams is making a comeback; these are the properties that built her $35 million real estate portfolio

Williams is one of the most successful athletes to ever take part in tennis, but she’s also been steadily building her collection of properties for many years.

Alanis Morissette quickly sells her Bay Area estate in lucrative $9.6 million sale

Acclaimed singer Alanis Morissette has proven that she can conquer not only the music charts, but also the real estate market.

Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial

The drugmaker’s shares tumbled in Copenhagen after saying a fifth of users discontinued its weight-loss drug because of gastrointestinal issues.

Nvidia strikes a new memory-chip deal — but SK Hynix and Samsung shares are under heavy pressure

South Korea’s once-hot Kospi index is headed for another day of sharp declines as the AI trade loses steam.

The Wegovy pill is still dominating the GLP-1 pill market

It has remained a top choice among Americans trying to lose weight even after the launch of Foundayo, Eli Lilly’s GLP-1 pill.

U.S. stock futures dip, oil prices surge as new attacks threaten the cease-fire with Iran

U.S. stock-index futures fell Sunday, after a massive tech selloff on Friday interrupted Wall Street’s two-month rally, and after new developments threatened the fragile cease-fire in the Iran war.

These are the market’s new hot stocks as investors flee from tech

Investors are suddenly dumping technology stocks and rotating into other areas — including health insurers, banks and retailers.

S&P 500 companies can’t stop talking about higher oil prices. But few say they’ll actually hit profits.

Only seven companies cited oil prices as a reason for cutting or not updating their profit outlooks for the year.

Tired of nausea or taking a GLP-1 pill every day? These experimental drugs could be better than Zepbound and Wegovy.

There is a new wave of weight-loss therapies in development that aim to be better than the existing GLP-1s.

The U.S. stock market is facing historic downside risk — these 10 low-volatility stocks can protect your portfolio

Low-volatility stocks give investors a smoother ride — and they are beating the market on a risk-adjusted basis.

The blowout jobs report is bad news for stocks — but it shouldn’t force the Fed’s hand on interest rates

Rate hikes now will choke off the critical investments needed to lower prices.

Can SpaceX live up to Wall Street’s multitrillion-dollar hype?

As SpaceX prepares for the biggest public debut in history, some analysts warn that the company’s “moonshot” projections could fall short.
1 50 51 52 53 54 2,679